Cohen & Steers Inc. (CNS) is a publicly traded Financial Services sector company. As of May 21, 2026, CNS trades at $71.63 with a market cap of $3.71B and a P/E ratio of 23.58. CNS moved -0.15% today. Year to date, CNS is +10.53%; over the trailing twelve months it is -11.12%. Its 52-week range spans $58.39 to $110.67. Analyst consensus is neutral with an average price target of $64.50. Rallies surfaces CNS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded CNS stock?
Recent politician trading activity in CNS includes disclosures from Gilbert Cisneros and Josh Gottheimer. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
CNS Key Metrics
Key financial metrics for CNS
Metric
Value
Price
$71.63
Market Cap
$3.71B
P/E Ratio
23.58
EPS
$3.03
Dividend Yield
0.67%
52-Week High
$110.67
52-Week Low
$58.39
Volume
213.12K
Avg Volume
0
Revenue (TTM)
$567.29M
Net Income
$155.33M
Gross Margin
0.00%
Congressional Trades in CNS
Gilbert Cisneros purchase CNS on Oct 30, 2025 (amount: $15.00K).
Josh Gottheimer sale CNS on Sep 25, 2024 (amount: $15.00K) for Joint.
Recent politician trading activity in CNS includes disclosures from Gilbert Cisneros and Josh Gottheimer. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in CNS?
Yes. Rallies tracks politician and congressional stock disclosures for CNS, including reported purchases, sales, dates, owners, and trade amounts when available.
Is CNS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CNS. It does not provide personalized investment advice.
